GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Aurisco Pharmaceutical Co Ltd (SHSE:605116) » Definitions » Market Cap

Aurisco Pharmaceutical Co (SHSE:605116) Market Cap : ¥8,250 Mil (As of Apr. 10, 2025)


View and export this data going back to 2020. Start your Free Trial

What is Aurisco Pharmaceutical Co Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Aurisco Pharmaceutical Co's share price for the quarter that ended in Sep. 2024 was ¥24.08. Aurisco Pharmaceutical Co's Shares Outstanding (EOP) for the quarter that ended in Sep. 2024 was 406 Mil. Therefore, Aurisco Pharmaceutical Co's market cap for the quarter that ended in Sep. 2024 was ¥9,781 Mil.

Aurisco Pharmaceutical Co's quarterly market cap increased from Mar. 2024 (¥8,953 Mil) to Jun. 2024 (¥10,167 Mil) but then declined from Jun. 2024 (¥10,167 Mil) to Sep. 2024 (¥9,781 Mil).

Aurisco Pharmaceutical Co's annual market cap increased from Dec. 2021 (¥8,830 Mil) to Dec. 2022 (¥10,029 Mil) and increased from Dec. 2022 (¥10,029 Mil) to Dec. 2023 (¥10,488 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Aurisco Pharmaceutical Co's Enterprise Value for Today is ¥7,676 Mil.


Aurisco Pharmaceutical Co Market Cap Historical Data

The historical data trend for Aurisco Pharmaceutical Co's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aurisco Pharmaceutical Co Market Cap Chart

Aurisco Pharmaceutical Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Market Cap
Get a 7-Day Free Trial - 6,363.87 8,830.02 10,028.95 10,487.95

Aurisco Pharmaceutical Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9,033.78 10,487.95 8,952.54 10,167.06 9,781.18

Competitive Comparison of Aurisco Pharmaceutical Co's Market Cap

For the Biotechnology subindustry, Aurisco Pharmaceutical Co's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Aurisco Pharmaceutical Co's Market Cap Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Aurisco Pharmaceutical Co's Market Cap distribution charts can be found below:

* The bar in red indicates where Aurisco Pharmaceutical Co's Market Cap falls into.


;
;

Aurisco Pharmaceutical Co Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Aurisco Pharmaceutical Co's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as

Market Cap (A: Dec. 2023 )=Share Price (A: Dec. 2023 )*Shares Outstanding (EOP) (A: Dec. 2023 )
=¥25.82*406.195
=¥10,488

Aurisco Pharmaceutical Co's Market Cap for the quarter that ended in Sep. 2024 is calculated as

Market Cap (Q: Sep. 2024 )=Share Price (Q: Sep. 2024 )*Shares Outstanding (EOP) (Q: Sep. 2024 )
=¥24.08*406.195
=¥9,781

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Aurisco Pharmaceutical Co  (SHSE:605116) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Aurisco Pharmaceutical Co Market Cap Related Terms

Thank you for viewing the detailed overview of Aurisco Pharmaceutical Co's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


Aurisco Pharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
Badu Industrial Park, Tiantai County, Zhejiang Province, Taizhou, CHN, 317200
Aurisco Pharmaceutical Co Ltd is engaged in production and sales of specialty APIs and pharmaceutical intermediates. The company's products include API's and Intermediates. Its products are supplied to Asia, Europe, America and Middle East through a well-established sales network.
Executives
Qiu Pei Jing Director
Zhao Zhen Ping senior management
Zhang Li Qin senior management

Aurisco Pharmaceutical Co Headlines

No Headlines